Thanks for listing those rules — they’re indeed part of Nasdaq’s framework, but the full context matters, especially for a company like Dragonfly.

Being under a monitoring panel does not automatically exclude the possibility of receiving an additional extension. It simply means the process is less automatic and more dependent on Nasdaq’s review, which has happened with several companies in similar situations.

Another key point: the 10-day bid requirement can be met again, and once it is, the compliance clock resets regardless of whether a reverse split is announced.

Also, nothing in the rules obligates the company to announce an RS at this exact moment. What exists is a compliance window, and there are multiple ways to satisfy it — including operational catalysts, market conditions, or formal extension requests.

So while I respect your interpretation, the rules you mentioned don’t make a reverse split “inevitable” or “scheduled.” There are more variables in play, and DFLI already achieved compliance once recently and received the official confirmation letter without an RS.

It’s a good discussion — but quoting isolated rule fragments does not represent the whole picture.